CD21 Monoclonal Antibody(2C5)

This gene encodes a membrane protein, which functions as a receptor for Epstein-Barr virus (EBV) binding on B and T lymphocytes. Genetic variations in this gene are associated with susceptibility to systemic lupus erythematosus type 9 (SLEB9). Alternatively spliced transcript variants encoding different isoforms have been found for this gene.

Introducing the CD21 Monoclonal Antibody (2C5), a cutting-edge product designed to revolutionize the field of immunology. This highly specialized antibody, developed through meticulous research and advanced technology, offers unparalleled specificity and efficacy in targeting CD21, a crucial cell surface receptor involved in immune response regulation.

The CD21 Monoclonal Antibody (2C5) is meticulously engineered to exhibit exceptional binding affinity and selectivity towards CD21, enabling precise and accurate detection and analysis of this receptor. Its monoclonal nature ensures consistent and reproducible results, making it an invaluable tool for researchers and clinicians alike.

With its exceptional performance, the CD21 Monoclonal Antibody (2C5) opens up a myriad of possibilities in various applications, including immunohistochemistry, flow cytometry, and western blotting. Its versatility allows for comprehensive investigation of CD21 expression patterns, facilitating a deeper understanding of its role in immune system functioning and disease progression.

Furthermore, the CD21 Monoclonal Antibody (2C5) boasts exceptional stability and reliability, ensuring consistent performance across multiple experiments and minimizing experimental variability. Its high-quality formulation guarantees long shelf life, making it a cost-effective and dependable choice for laboratories and research institutions.

In summary, the CD21 Monoclonal Antibody (2C5) represents a breakthrough in immunological research, offering unmatched specificity, reliability, and versatility. With its exceptional performance and advanced features, this antibody is poised to revolutionize the field and drive new discoveries in immunology.